Learn how ECG noise filtering that adapts to noise type improved QT and QRS accuracy and supports more reliable cardiac ...
Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature. Researchers have now found a way to ...
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. These are all cases of sudden cardiac arrest: when the heart ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Cardiac fibrosis impacts millions of patients and currently has no effective therapy. Stanford Cardiovascular Institute researchers have uncovered a new mechanosensing-based mechanism that reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback